about
The Role of PPARs in CancerInteraction of cyclin-dependent kinase 12/CrkRS with cyclin K1 is required for the phosphorylation of the C-terminal domain of RNA polymerase IIInterplay between lysine methylation and Cdk phosphorylation in growth control by the retinoblastoma proteinMicroRNA aberrations: An emerging field for gallbladder cancer managementStudies of Tumor Suppressor Genes via Chromosome EngineeringTherapeutic Implications for Overcoming Radiation Resistance in Cancer TherapyHuman Papilloma Virus (HPV) Induced Head & Neck Squamous Cell Carcinoma: A Comprehensive RetrospectDiffuse anterior retinoblastoma: current conceptsDysregulated transcriptional and post-translational control of DNA methyltransferases in cancerTargeting cyclin-dependent kinases in human cancers: from small molecules to Peptide inhibitorsTGF-β cascade regulation by PPP1 and its interactors -impact on prostate cancer development and therapyExtra-cell cycle regulatory functions of cyclin-dependent kinases (CDK) and CDK inhibitor proteins contribute to brain development and neurological disordersA role of WT1 in cell division and genomic stabilityEfficient photodynamic therapy on human retinoblastoma cell linesMitotic catastrophe occurs in the absence of apoptosis in p53-null cells with a defective G1 checkpointPax6-positive Müller glia cells express cell cycle markers but do not proliferate after photoreceptor injury in the mouse retinaAh Receptor Pathway Intricacies; Signaling Through Diverse Protein Partners and DNA-MotifsRole of cell cycle regulators in lung carcinogenesisGenome-wide profile of pleural mesothelioma versus parietal and visceral pleura: the emerging gene portrait of the mesothelioma phenotypeMechanism-based screen for G1/S checkpoint activators identifies a selective activator of EIF2AK3/PERK signallingOverexpression of CARMA3 in non-small-cell lung cancer is linked for tumor progressionMolecular basis for viral selective replication in cancer cells: activation of CDK2 by adenovirus-induced cyclin ETranscriptome analysis of tetraploid cells identifies cyclin D2 as a facilitator of adaptation to genome doubling in the presence of p53Expression of the lncRNA Maternally Expressed Gene 3 (MEG3) Contributes to the Control of Lung Cancer Cell Proliferation by the Rb PathwayPFK15, a Small Molecule Inhibitor of PFKFB3, Induces Cell Cycle Arrest, Apoptosis and Inhibits Invasion in Gastric CancerCell proliferation and expression of cell cycle regulatory proteins that control the G1/S transition are age dependent and lobe specific in the Brown Norway rat model of prostatic hyperplasiaRole of mammalian Ecdysoneless in cell cycle regulationThe role of Cdc25A in the regulation of cell proliferation and apoptosisTranslation initiation factor eIF3b expression in human cancer and its role in tumor growth and lung colonizationAlterations in mitosis and cell cycle progression caused by a mutant lamin A known to accelerate human agingAurora B kinase regulates the postmitotic endoreduplication checkpoint via phosphorylation of the retinoblastoma protein at serine 780A non-negative matrix factorization method for detecting modules in heterogeneous omics multi-modal data.Data Requirements for Model-Based Cancer Prognosis PredictionExpression and Therapeutic Potential of SOX9 in Chordoma.The lin-35/Rb and RNAi pathways cooperate to regulate a key cell cycle transition in C. elegans.Up regulation in gene expression of chromatin remodelling factors in cervical intraepithelial neoplasia.pRb2/p130 protein expression and RBL2 mutation analysis in Burkitt lymphoma from UgandaSNORD76, a box C/D snoRNA, acts as a tumor suppressor in glioblastomaOncogenic roles of SMARCB1/INI1 and its deficient tumorsDefective lamin A-Rb signaling in Hutchinson-Gilford Progeria Syndrome and reversal by farnesyltransferase inhibition.
P2860
Q21342955-248D0C04-D294-47E7-954A-F3A4CBA688D2Q24299038-6FF37992-8E17-4788-8ED4-3887F52A766CQ24310370-0472728B-78FA-48C7-99EB-09B645AEE01CQ26768416-C918ABC8-EE72-4416-8E23-90FC33D9CE16Q26771240-C63CFB9C-8394-4626-A203-7B4D9E2059BDQ26777016-5B3C45CA-69FE-4F7E-82ED-E6941A6DA130Q26798802-134F9496-EBD0-4533-AB57-2C6D5CB62D22Q26801127-BEE7A762-AF18-43BC-BD72-7AED05305D02Q26827297-72F6EC76-BCA2-4623-BA5D-FFB284491E5DQ26827580-9A81ECB2-941C-4EB9-8BE5-C3619E709562Q26862838-EED5E8E4-E014-4077-804D-9765BA5D0794Q26864155-0201BBD4-26B5-4CD4-97FF-16D7759AAF3CQ27009003-5ADB2517-D2E4-45E0-8D27-F4B444D6B5CCQ27324555-B4F3B7D5-A3D2-4F16-9755-EDE4C40DE29CQ27329415-2AE05CA2-F535-4FF0-A459-6815368D6501Q28235783-5571C326-C258-44C2-8744-AB2582624C49Q28384227-351E52F6-7404-4444-9F21-42A47566F0DAQ28394676-23228003-9D6C-4EB3-9EC5-9A4D989CEF71Q28475905-10008E3F-6E1B-4D2A-81E9-53F1A33EA5A1Q28478858-4331D052-FCD3-4E80-B2A1-08B24FABB88CQ28483701-046CEFD7-4118-4C89-8952-C07F184D816EQ28486255-25B6C8D0-9637-4F8A-8370-C319951AE07FQ28552677-D0A9FE0F-5072-4C52-A78C-A66435167CF9Q28553467-57300A3E-DA0E-4644-9EA5-285318B6EB7BQ28554349-5371DAF1-F2BD-40B2-8FA5-C87106796E90Q28572109-CBD691B4-F28A-421F-A7D0-8F70168CE197Q28588460-EA4680B0-FC54-487B-8E72-743A92C4741FQ28611420-C575AA43-DA9F-48D3-9AAD-2BA402DB64AFQ30416020-5D4B2747-15A5-4838-B74B-304D21F03EAAQ30479111-3DD54B4E-98FF-4827-8E4A-CE20829F2147Q30487026-04B13F28-3D54-4B0D-AB72-0E10132C30DDQ30993887-65DBEC67-FD55-47E7-88B3-FF155410B710Q31087381-EEFE3A62-C428-4599-90CC-D3F5D4ACF8E2Q33276544-39ED939E-5FCE-44FB-9CDE-F44EABB5C94BQ33283088-CE1A5B62-2D74-442F-8857-71C4FB1D2EA0Q33318134-B39B9C3D-2499-4403-8438-487D53EE0122Q33494956-4B003615-7B5A-4D94-9C3E-BCB921481DAFQ33559570-D81112F4-8A04-4280-A6C7-8F986854C69EQ33607443-9CD44E7C-1954-4206-A08E-6C4C1B4CA821Q33608779-947B9B2D-9886-4136-B0C1-D454B275A623
P2860
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
RB and cell cycle progression.
@ast
RB and cell cycle progression.
@en
type
label
RB and cell cycle progression.
@ast
RB and cell cycle progression.
@en
prefLabel
RB and cell cycle progression.
@ast
RB and cell cycle progression.
@en
P356
P1433
P1476
RB and cell cycle progression.
@en
P2093
Giacinti C
P2888
P304
P356
10.1038/SJ.ONC.1209615
P407
P577
2006-08-01T00:00:00Z
P5875
P6179
1017613716